This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 May;78(5):896-897.

doi: 10.1016/j.jhep.2023.02.018. Epub 2023 Feb 26.

Methotrexate-induced liver fibrosis: The end of a long-held belief

Vincent Di Martino¹

Affiliations

Affiliation

¹ Department of Hepatology, CHRU Jean Minjoz, EA 4266 EPILAB, UFR Santé, University of Franche-Comté, INSERM UMR RIGHT 1098, Besançon, France. Electronic address: vdimartino@chu-besancon.fr.

PMID: 36854346
DOI: 10.1016/j.jhep.2023.02.018

Editorial

Methotrexate-induced liver fibrosis: The end of a long-held belief

Vincent Di Martino. J Hepatol. 2023 May.

. 2023 May;78(5):896-897.

doi: 10.1016/j.jhep.2023.02.018. Epub 2023 Feb 26.

Author

Vincent Di Martino¹

Affiliation

¹ Department of Hepatology, CHRU Jean Minjoz, EA 4266 EPILAB, UFR Santé, University of Franche-Comté, INSERM UMR RIGHT 1098, Besançon, France. Electronic address: vdimartino@chu-besancon.fr.

PMID: 36854346
DOI: 10.1016/j.jhep.2023.02.018

No abstract available

PubMed Disclaimer

Comment on

Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
Atallah E, Grove JI, Crooks C, Burden-Teh E, Abhishek A, Moreea S, Jordan KM, Ala A, Hutchinson D, Aspinall RJ, Murphy R, Aithal GP. Atallah E, et al. J Hepatol. 2023 May;78(5):989-997. doi: 10.1016/j.jhep.2022.12.034. Epub 2023 Jan 23. J Hepatol. 2023. PMID: 36702175

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information